Phase I Study of Gimatecan in Patients With Myelodysplastic Syndromes

NCT00493571 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Myelodysplastic Syndromes
MDS

Interventions

DRUG: Gimatecan

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]